|
AMOTL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.322700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.925780E-02 |
| Normal-vs-Stage2 |
2.434400E-01 |
| Normal-vs-Stage3 |
3.689800E-01 |
| Normal-vs-Stage4 |
3.140800E-01 |
| Stage1-vs-Stage2 |
9.457600E-01 |
| Stage1-vs-Stage3 |
6.350800E-01 |
| Stage1-vs-Stage4 |
1.161220E-01 |
| Stage2-vs-Stage3 |
7.808200E-01 |
| Stage2-vs-Stage4 |
1.639780E-01 |
| Stage3-vs-Stage4 |
2.618600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.896700E-03 |
| Normal-vs-AfricanAmerican |
7.741600E-02 |
| Normal-vs-Asian |
7.086200E-01 |
| Caucasian-vs-AfricanAmerican |
6.335600E-01 |
| Caucasian-vs-Asian |
2.701400E-01 |
| AfricanAmerican-vs-Asian |
2.804200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.280440E-01 |
| Normal-vs-Female |
6.44159999999561E-05 |
| Male-vs-Female |
5.847400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.003000E-01 |
| Normal-vs-Extreme_Weight |
5.132200E-01 |
| Normal-vs-Obese |
3.476500E-03 |
| Normal-vs-Extreme_Obese |
8.536200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.748200E-01 |
| Normal_Weight-vs-Obese |
1.327630E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.614000E-01 |
| Extreme_Weight-vs-Obese |
1.291750E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.608200E-01 |
| Obese-vs-Extreme_Obese |
1.832200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.261560E-01 |
| Normal-vs-Age(41-60Yrs) |
2.181700E-03 |
| Normal-vs-Age(61-80Yrs) |
5.745900E-02 |
| Normal-vs-Age(81-100Yrs) |
8.345200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.716400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.151800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.262390E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.216380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.932480E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.085800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.455300E-03 |
| Normal-VS-Type2 PRCC |
9.102000E-01 |
| Normal-VS-KIRP CIMP |
1.912150E-01 |
| Normal-VS-Unclassified PRCC |
8.640500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.984600E-04 |
| Type1 PRCC-VS-KIRP CIMP |
4.409200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.789780E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.795180E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.601000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.627200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.856000E-01 |
| Normal-vs-N1 |
3.954600E-01 |
| Normal-vs-N2 |
4.601000E-01 |
| N0-vs-N1 |
6.712600E-01 |
| N0-vs-N2 |
8.197200E-01 |
| N1-vs-N2 |
9.986000E-01 |
|
|
